Birmingham, West Midlands -- (SBWIRE) -- 01/28/2014 -- Value Penny Stocks issues special report on Cirrus Logic, Inc. (NASDAQ:CRUS), Riverbed Technology, Inc. (NASDAQ:RVBD), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Sonus Networks, Inc. (NASDAQ:SONS).
Cirrus Logic, Inc. (NASDAQ:CRUS) ended its recent business day with the loss of -0.25% and closed at the price of $19.62 after opening at $19.81. The stock traded during its last trading session with the total volume of 2,410,937 shares, as compared to its average volume of 1.90 million shares. Cirrus Logic, Inc., a fabless semiconductor company, develops analog and mixed-signal integrated circuits (ICs) for a range of consumer and industrial markets. The company offers audio products, including analog-to-digital converters (ADCs), digital-to-analog converters (DACs), codecs, digital interface ICs, volume controls, adaptive noise cancelling circuits, and amplifiers, as well as audio digital signal processors.
Has CRUS Found The Bottom and Ready To Move Up? Find Out Here
Riverbed Technology, Inc. (NASDAQ:RVBD) remained among the day decliners and traded with volume of 2,289,152 shares in the last session, as compared to average volume of 2.55 million shares. In comparison with 52 week range of $13.77 - $21.07, it faced lowest price of $19.24 during the last trading session whereas its day highest price was $19.99. The company’s total market capitalization is $3.16 billion, along with 161.87 million shares outstanding. Riverbed Technology, Inc. provides solutions to the fundamental problems associated with information technology (IT) performance across wide area networks (WANs) in the United States and internationally. It offers Steelhead products, which enable customers to enhance the performance of applications and access data across WANs.
Has RVBD Found The Bottom And Ready To Gain Momentum? Find Out Here
Halozyme Therapeutics, Inc. (NASDAQ:HALO) showed 2,262,584 shares in volume during the last trading session, while the average trading volume remained 1.61 million shares. The stock kicked off its trading session at $16.75 and closed at $15.87 after declining -4.11%. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
Why Should Investors Buy HALO After the Recent Fall? Just Go Here and Find Out
Sonus Networks, Inc. (NASDAQ:SONS) stock traded during its last trading session with the total traded volume of 2,246,276 shares versus its average volume of 1.16 million shares. The company opened its trade at the price of $2.95 and its closing price was $2.98 after gaining 1.02% for the day. Sonus Networks, Inc. provides networked solutions for communications service providers and enterprises in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its solutions address the need to link and leverage multivendor, multiprotocol communications systems and applications across customer’s networks.
Why Should Investors Buy SONS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)